Korean Journal of Health Education and Promotion (보건교육건강증진학회지)

Korean Society for Health Education and Promotion (한국보건교육건강증진학회)
권호 표지
DOI QR코드

DOI QR Code

Related factors of medication adherence in patients with dyslipidemia: The 2010-2012 Korean National Health and Nutrition Examination Survey

이상지질혈증 환자의 약물복용 이행과 관련된 요인: 2010년-2012년 국민건강영양조사를 이용하여

  • Received : 2015.04.30
  • Accepted : 2015.06.23
  • Published : 2015.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: The purpose of this study was to examine factors that influencing medication adherence in patients with dyslipidemia. Methods: Data were collected from fifth Korean National Health and Nutrition Examination Survey (2010-2012), we selected 1,992 adults aged over 30yr who participants in both health examination and health interview survey. Using the SAS 9.2 Program, data were analyzed using ${\chi}^2$-test, t-test and multiple logistic regression. Results: Medication adherence was associated with age, obesity, educational level and Health screening within 2 years. The cases with older age, obesity, higher level of education and experience of Health screening within 2 years showed significantly high medication adherence, whereas high risk group of dyslipidemia such as cardiovascular disease patients showed low medication adherence. Conclusions: Further study and strategies are needed to improve high levels of medication adherence based on factors influencing such as age, obesity, level of education and health screening experience within 2 years.

Keywords

References

  1. Abou-Setta, A. M., Beaupre, L. A., Jones, C. A., Rashiq, S., Hamm, M. P., Sadowski, C. A., Dryden, D. M. (2011). AHRQ Comparative Effectiveness Reviews Pain Management Interventions for Hip Fracture. Rockville (MD): Agency for Healthcare Research and Quality (US).
  2. Bouchard, M. H., Dragomir, A., Blais, L., Berard, A., Pilon, D., & Perreault, S. (2007). Impact of adherence to statins on coronary artery disease in primary prevention. Br J Clin Pharmacol, 63(6), 698-708. doi: 10.1111/j.1365-2125.2006.02828.x
  3. CDC's Noon Conference. (2013). Medication Adherence. Primary care educators may use the following slides for their own teaching purpose. http://www.cdc.gov/primarycare/materials/medication/docs/medication-adherence-01ccd.pdf
  4. Cho B, L. C. (2011). Current situation of national health screening systems in Korea Journal of the Korean Medical Association, 54(7), 666-669. https://doi.org/10.5124/jkma.2011.54.7.666
  5. Cho, H. j. (2010). A study on the prescription aspects for dyslipidemia patients in a university hospital located in Daegu. (M.S. Thesis), Department of Clinical Pharmacy Graduate School Yeungnam University, Gyeongsan. Retrieved from http://www.riss.kr/link?id=T12187366
  6. Clark, A., DesMeules, M., Luo, W., Duncan, A., & Wielgosz, A. (2009). Socioeconomic status and cardiovascular disease: risks and implications for care. Nat Rev Cardiol, 6(11), 712-722. https://doi.org/10.1038/nrcardio.2009.163
  7. Collins, R., Armitage, J., Parish, S., Sleigh, P., & Peto, R. (2003). MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet, 361(9374), 2005-2016. https://doi.org/10.1016/S0140-6736(03)13636-7
  8. Cramer, J. A., Roy, A., Burrell, A., Fairchild, C. J., Fuldeore, M. J., Ollendorf, D. A., & Wong, P. K. (2008). Medication compliance and persistence: terminology and definitions. Value Health, 11(1), 44-47. doi: 10.1111/j.1524-4733.2007.00213.x
  9. De Caterina, R. (2015). The new ACCF/AHA guidelines on the treatment of dyslipidemia: pros. Intern Emerg Med, 10(2), 115-117. doi: 10.1007/s11739-014-1159-3
  10. Ellis, J. J., Erickson, S. R., Stevenson, J. G., Bernstein, S. J., Stiles, R. A., & Fendrick, A. M. (2004). Suboptimal statin adherence and discontinuation in primary and secondary prevention populations. J Gen Intern Med, 19(6), 638-645. doi: 10.1111/j.1525-1497.2004.30516.x
  11. Foody, J. M., Joyce, A. T., Rudolph, A. E., Liu, L. Z., & Benner, J. S. (2008). Persistence of atorvastatin and simvastatin among patients with and without prior cardiovascular diseases: a US managed care study. Curr Med Res Opin, 24(7), 1987-2000. doi: 10.1185/03007990802203279
  12. Gomez Sandoval, Y. H., Braganza, M. V., & Daskalopoulou, S. S. (2011). Statin discontinuation in high-risk patients: a systematic review of the evidence. Curr Pharm Des, 17(33), 3669-3689. https://doi.org/10.2174/138161211798220891
  13. Han M, J. (2008). association between metabolic syndrome and coronary artery disease angiographic severity. (Master's degree), Seoul. Retrieved from http://www.riss.kr/link?id=T11216070
  14. Hyun Ja Kim, Y. K., Yumi Cho , Byungyool Jun, KyungWon Oh. (2014). Trends in the prevalence of major cardiovascular disease risk factors among Korean adults: Results from the Korea National Health and Nutrition Examination Survey, 1998-2012. International Journal of Cardiology, 174, 64-72. https://doi.org/10.1016/j.ijcard.2014.03.163
  15. Jun-Beom Park , Kyungdo Han, Yong-Gyu Park , Youngkyung Ko (2014). Association Between Alcohol Consumption and Periodontal Disease: The 2008-2010 Korea National Health and Nutrition Examination Survey. Journal of Periodontology;.
  16. Knhanse. (2013). Community health service KCDC.
  17. Lee, M. H., Kim, H. C., Ahn, S. V., Hur, N. W., Choi, D. P., Park, C. G., & Suh, I. (2012). Prevalence of Dyslipidemia among Korean Adults: Korea National Health and Nutrition Survey 1998-2005. Diabetes Metab J, 36(1), 43-55. doi: 10.4093/dmj.2012.36.1.43
  18. Liberopoulos, E. N., Florentin, M., Mikhailidis, D. P., & Elisaf, M. S. (2008). Compliance with lipid-lowering therapy and its impact on cardiovascular morbidity and mortality. Expert Opin Drug Saf, 7(6), 717-725. doi: 10.1517/14740330802396984
  19. MacLaughlin, E. J., Raehl, C. L., Treadway, A. K., Sterling, T. L., Zoller, D. P., & Bond, C. A. (2005). Assessing medication adherence in the elderly: which tools to use in clinical practice? Drugs Aging, 22(3), 231-255. https://doi.org/10.2165/00002512-200522030-00005
  20. Marcum, Z. A., Sevick, M. A., & Handler, S. M. (2013). Medication nonadherence: a diagnosable and treatable medical condition. Jama, 309(20), 2105-2106. doi: 10.1001/jama.2013.4638
  21. MHW. (2013). Community health survey
  22. Nam, G. E., Cho, K. H., Park, Y. G., Han, K. D., Choi, Y. S., Kim, S. M., Kim do, H. (2013). Socioeconomic status and dyslipidemia in Korean adults: the 2008-2010 Korea National Health and Nutrition Examination Survey. Prev Med, 57(4), 304-309. doi: 10.1016/j.ypmed.2013.06.008
  23. NIH. (2002). Detection, Evaluation,and Treatmentof High BloodCholesterol in Adults(Adult Treatment Panel III) (L. National Cholesterol Education Program National Heart, and Blood Institute, Trans.).
  24. Okamura, T. (2010). Dyslipidemia and Cardiovascular Disease: A Series of Epidemiologic Studies in Japanese Populations. J Epidemiol, 20(4), 259-265. https://doi.org/10.2188/jea.JE20100060
  25. Rae, L. N. (2012). Factors of Taking a Health Examinatio. (master's degree), Korea University Seoul. Retrieved from http://www.riss.kr/link?id=T12868078
  26. Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Benjamin, E. J., Berry, J. D., Borden, W. B., Turner, M. B. (2012). Executive summary: heart disease and stroke statistics 2012 update: a report from the American Heart Association. Circulation, 125(1), 188-197. doi: 10.1161/CIR.0b013e3182456d46
  27. Toth, P. P. (2008). Subclinical atherosclerosis: what it is, what it means and what we can do about it. Int J Clin Pract, 62(8), 1246-1254. https://doi.org/10.1111/j.1742-1241.2008.01804.x
  28. Wang, S., Xu, L., Jonas, J. B., You, Q. S., Wang, Y. X., & Yang, H. (2011). Prevalence and associated factors of dyslipidemia in the adult Chinese population. PLoS One, 6(3), e17326. doi: 10.1371/journal.pone.0017326
  29. WHO. (2003). Adherence to Long-Term Therapies-Evidence for Action [Internet]. http://apps.who.int/medicinedocs/en/d/Js4883e/ (1 January 2014
  30. Zambon, A. (2015). The new ACC/AHA guidelines on the treatment of dyslipidemia: cons. Intern Emerg Med, 10(2), 119-122. doi: 10.1007/s11739-014-1165-5

Cited by

  1. 한국인의 이상지질혈증 발생 위험 요인 및 약물복용이행 영향 요인 평가: 2013-2015 국민건강영양조사 자료 이용 vol.19, pp.3, 2017, https://doi.org/10.7586/jkbns.2017.19.3.131
  2. 크릴 분말 및 NaF 첨가 식이가 흰쥐의 혈청 지질성분 및 혈당 변동에 미치는 영향 vol.34, pp.4, 2015, https://doi.org/10.12925/jkocs.2017.34.4.938
  3. Association between Patient Experience and Medication Compliance of Dyslipidemia: Using Korea National Health and Nutrition Examination Survey (2015) vol.42, pp.2, 2015, https://doi.org/10.4082/kjfm.19.0128